$4.505
0.065[1.46%]
Last update: 10:18AM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$4.51
0.0050[0.11%]
| Open4.480 | Close- |
| Vol / Avg.749.448K / 6.142M | Mkt Cap1.116B |
| Day Range4.425 - 4.570 | 52 Wk Range4.410 - 10.410 |
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%
Iovance Biotherapeutics Stock (NASDAQ:IOVA), Key Statistics
Iovance Biotherapeutics Stock (NASDAQ: IOVA) analysis, key statistics.
Valuation Measures
Enterprise Value
929.9M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
3548.65
Price / Book (mrq)
1.9
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-50.9%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.34
Tangible Book value per share
1.38
Total Liabilities (Quarterly)
178.7M
Total Assets
757.3M
Total Liabilities
178.7M
Profitability
Net income Growth
- -
Gross Margin
-761.34%
Net Margin
-44759.66%
EBIT Margin
-46254.62%
EBITDA Margin
-42960.08%
Operating Margin
-46254.62%